about
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help c...
Read More
11.83
0.04
(0.34%)
35,316
XNAS Volume
XNAS 19 Sep, 2025 9:52 AM (EDT)
Medium Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks.
View Similar
Embed DVM
Certara Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..